Moreover, the aberrant expression of tumor necrosis factor receptor-associated factor 6 (TRAF6), a TLR effector with ubiquitin (Ub) ligase activity, has been observed to contribute to ineffective hematopoiesis in MDS [37]. This evidence concerns the gene TRAF6 and myelodysplastic syndrome.